Considering the vital role of the TLR4–NF-κB signaling pathway in mediating the synergistic stimulation of spike protein and IL-2 in inducing inflammatory cytokines, this pathway presents a promising target for preventing or reducing CRS in patients with COVID-19. Here, CHMP5 is linked to congenital rubella syndrome.